We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

QLT Unit Pays $112.5M To Resolve Drug Dispute

Law360 (February 9, 2007, 12:00 AM EST) -- A U.S. unit of Canada’s generic drug maker QLT Inc. has agreed to shell out $112.5 million to settle a patent infringement lawsuit over its prostate cancer drug Eligard.

QLT USA...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.